Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Cytori Therapeutics, Inc.

TRADE

NASDAQ: CYTXWHealthcare / Biotechnology / USA
0.0100.00Vol 14 2771Y Perf -75.00%
Oct 18th, 2018 10:01
BID0.00 ASK0.01
Open0.01 Previous Close0.01
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Price Range Ratio 52wk %
0.00 
Earnings Date

Today's Price Range

0.010.01

 

52wk Range

0.010.05

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
-
3 Months
0.00%
6 Months
-50.00%
1 Year
-75.00%
3 Years
-
5 Years
-98.57%

Quotes

Name / TickerPriceChg.Chg.%
CYTXW0.010.00000.00
AAPL218.71-2.4800-1.12
GOOG1 100.91-14.7800-1.32
MSFT109.46-1.2500-1.13
XOM82.060.56000.69
WFC53.96-0.5000-0.92
JNJ138.81-0.6500-0.47
FB156.71-2.7100-1.70
GE12.350.16001.31
JPM109.44-0.3900-0.36
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.20
Current Ratio 0.40
Long Term Debt to Total Capital 0.41
Total Debt to Equity 2.91
Interest Coverage -8.60
Leverage Ratio 3.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin62.70
EBIT Margin-246.30
EBITDA Margin-213.10
Pre-tax Profit Margin-283.00
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio -
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -
Cash Flow Per Share -
Price to Tangible Book-
Book Value per Share-
Enterprise Value (in ths.)-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-412.90
ROE last 12 Months -260.39
Return on Assets (5Y Avg) -93.60
ROA last 12 Months -75.64
Return on Capital (5Y Avg) -
ROC last 12 Months -106.05
Return on invested Capital Q -15.79
Return on invested Capital Y-111.43
Assets Turnover0.10
Receivables Turnover3.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 919
Revenue per Share -
Revenue Growth 3 Years -28.54
Revenue Growth 5 Years -16.56
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume14 277
Shares Outstanding (in ths.)0
Trades Count10
Dollar Volume213
Avg. Volume25 886
Avg. Weekly Volume26 080
Avg. Monthly Volume49 275
Avg. Quarterly Volume33 457

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

65%35%

Bearish Bullish

56%44%

Bearish Bullish

69%31%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x